Hims & Hers Health Surges to 169th in Trading Volume with $977 Million Day

On April 9, 2025, Hims & Hers Health (HIMS) saw a significant surge in trading volume, reaching $977 million, marking a 33.76% increase from the previous day. This substantial rise placed HIMS at the 169th position in terms of trading volume for the day, with the stock price increasing by 12.99%.

Hims & Hers Health has been experiencing robust growth, driven by its integrated experience, strong brand recognition, and a convenient, stigma-free value proposition for consumers. This has led to a substantial increase in revenue, with the company reporting $481 million in revenue for the fourth quarter of 2024, a 95% increase year-over-year.

ExodusPoint Capital Management LP significantly increased its stake in Hims & Hers Health, Inc. by 138.3% in the fourth quarter, indicating strong institutional confidence in the company's growth prospects. This move underscores the belief in Hims & Hers Health's consistent growth trajectory within the healthcare sector.

Analysts have also taken note of Hims & Hers Health's potential. Morgan Stanley analyst Craig Hettenbach maintained a buy rating for the company, setting a target price of $42. This positive outlook from a major financial institution further supports the company's strong performance and future growth potential.